NI Medical’s non-invasive solution is uniquely designed to enable physicians to measure cardiac parameters in various settings, such as patients’ homes, clinics, hospitals, and ICUs. NICaS technology provides you with a personalized profile, which enables personalized treatment.
NICaS, the non-invasive hemodynamic & fluid measuring system, provides each patient with a personal hemodynamic profile – information otherwise available only in high-level hospital care.
With this information, healthcare providers are able to treat their patients better, resulting in a substantial reduction in readmission rates, thus lowering the economic, as well as clinical, burden of Heart Failure.
Our Technology was developed to improve medical outcomes, both in chronic and acute conditions, and in various clinical applications including: heart failure, hypertension, preeclampsia management, hemodialysis and dialysis, CRT optimization, hemodynamic monitoring during anesthesia and infectious disease hemodynamic management.
The technology is FDA approved, CE marked and cleared for marketing in many countries worldwide for monitoring hemodynamic parameters, including stroke volume, stroke index, heart rate, cardiac index, cardiac output, and total peripheral resistance.
In addition, it has a patent for its GGI parameter, an innovative assessment tool that is able to detect the smallest decrease of the left ventricular function.
Number of heart beats per minute
Amount of blood pumped by Left ventricle with each heart beat
Stroke volume normalized for body surface area
Amount of blood pumped by the left ventricle per minute
Cardiac Output normalized for body surface area
Cardiac output/Body surface area
An indicator of the left ventricular function
The resistance to the flow of blood in the arterial system (“Afterload”)
The resistance to the flow of blood in the arterial system normalized for body surface area
Patient’s fluid content
Number of breaths per minute
Readmission & Hospitalization Reduction
Heart failure is responsible for 11 million physician visits each year and leads to more hospitalizations than all forms of cancer combined.
NICaS can help reduce hospitalization and readmission rates. This technology can assist in the assessment and management of CHF patients in various settings.
Related Clinical Studies
Non-Invasive Hemodynamic Whole-Body Bioimpedance Indices for the Early Detection of Cancer Treatment-Related Cardiotoxicity: A Retrospective Observational Study
Authors: Nili Schamroth Pravda, Shaul Lev , Osnat Itzhaki Ben Zadok, Ran Kornowski, Zaza Iakobishvili Conclusion: GGI, a parameter measured by WBI, can reliably correlate
Authors: Gad Cotter , Yaron Moshkovitz, Edo Kaluski, Amram J Cohen, Hilton Miller, Daniel Goor, Zvi Vered The results of the study indicate that the
Authors: Nathan W Levin MD FACP1, Marcia H. F. G de Abreu MD2, Lucas E. Borges MD, Helcio A. Tavares Filho, Rabia Sarwar, MD3Surendra Gupta,
Authors: Ruth Rafaeli Rabin , Ilya Rosin , Avraham Matitiau , Yael Simpson , Orna Flidel-Rimon Conclusion: We found significant differences in hemodynamic parameters between
Hemodynamic response to fluid removal during hemodialysis: categorization of causes of intradialytic hypotension
Authors: Nathan W Levin , Marcia H F G de Abreu , Lucas E Borges , Helcio A Tavares Filho , Rabia Sarwar , Surendra